-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
According to the website of the Shanghai Municipal People's Government on the 21st, the General Office of the Shanghai Municipal People's Government recently issued "Several Policies and Measures for Shanghai to Accelerate the Construction of a Global Biomedical R&D Economic and Industrialization Highland"
.
.
It is proposed that by 2025, Shanghai's global biomedical R&D economy and industrialization highland development pattern will initially take shape, the overall scale of R&D economy will reach more than 100 billion yuan, and more than 100 innovative drugs and medical devices will be cultivated or introduced Heavy products, cultivate more than 50 innovative headquarters with compound functions such as biomedical R&D, sales and settlement, cultivate more than 20 high-level biomedical incubators and accelerators, promote the listing and trading of more than 1,000 biomedical patents in Shanghai, add more than 5 biomedical municipal engineering research centers, and provide innovative services
such as engineering verification and transformation for more than 100 early high-quality achievements of universities and research institutes.
such as engineering verification and transformation for more than 100 early high-quality achievements of universities and research institutes.
By 2030, Shanghai's status as a global biomedical R&D economy and industrialization highland will be further highlighted, the overall scale of R&D economy will be further improved, a number of innovative drugs and medical device blockbuster products developed and listed in Shanghai will emerge, and a number of biomedical innovative headquarters and innovation platforms with domestic and foreign influence will be gathered, and the R&D economy will become an important supporting force
for the development of the city's biomedical industry.
for the development of the city's biomedical industry.